Signal peptides: New markers in cardiovascular disease?

Biomarkers in Medicine

Volumn 8, Issue 8, 2014, Pages 1013-1019

  Pemberton, Chris J ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

cardiovascular biomarkers; nonclassical secretion; plasma proteome; signal peptides

Indexed keywords

APOLIPOPROTEIN M; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; LIPID; SIGNAL PEPTIDE; BIOLOGICAL MARKER; PEPTIDE FRAGMENT;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL DECISION MAKING; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE MARKER; EVIDENCE BASED MEDICINE; FERTILITY; HIGH RISK POPULATION; HUMAN; IMMUNOREGULATION; NONHUMAN; PEPTIDE ANALYSIS; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN SECRETION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; REVIEW; SIGNAL PEPTIDE BLOOD LEVEL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYMPTOM; CARDIOVASCULAR DISEASES; METABOLISM; PROGNOSIS;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HUMANS; PEPTIDE FRAGMENTS; PROGNOSIS; PROTEIN SORTING SIGNALS;

EID: 84908288447     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.14.64     Document Type: Review

References (46)

1. Thygesen K, Alpert JS, Jaffe AS et al. Joint ESC/ACCF/ AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. Circulation 126, 2020-2035 (2012
2. McMurray JJ, Adamopoulos S, Anker SD et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Eur. Heart J. 33(14), 1787-1847 (2012
3. Maisel A, Mueller C, Neath SX et al. Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection of patients with acute myocardial infarction). J. Am. Coll. Cardiol. 62, 150-160 (2013
4. Januzzi JL Jr. ST2 as a cardiovascular risk biomarker: from the bench to the beside. J. Cardiovasc. Transl. Res. 6(4), 493-500 (2013
5. Eggers KM, Kempf T, Allhoff T, Lindahl B, Wallentin L, Wollert KC. Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain. Eur. Heart J. 29, 2327-2335 (2008
6. Potocki M, Ziller R, Mueller C. Mid-regional pro-Adrenomedullin in acute heart failure: a better biomarker or just another biomarker?. Curr. Heart Fail. Rep. 9(3), 244-251 (2012
7. McCullough PA, Olobatoke A, Vanhecke TE. Galectin-3: a novel test for the evaluation and management of patients with heart failure. Rev. Cardiovasc. Med. 12(4), 200-210 (2011
8. Nickel W. The mystery of nonclassical protein secretion. Eur. J. Biochem. 270, 2109-2119 (2003
9. Nickel W. Unconventional secretory routes: direct protein export across the plasma membrane of mammalian cells. Traffic 6, 607-614 (2005
10. Anderson NL. The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum. Clin. Chem. 56(2), 177-185 (2010
11. Blobel G, Sabatini D. Ribosome-membrane interaction in eukaryotic cells. In: Biomembranes. Manson L (Ed.). Plenum Press, New York, NY, USA, 193-195 (1971
12. Blobel G. Protein targeting (Nobel lecture). ChembioChem. 1, 86-102 (2000
13. Von Heijne G. The signal peptide. J. Membr. Biol. 115, 195-201 (1990
14. Novak P, Dev I. Degradation of a signal peptide by protease IV and oligopeptidase A. J. Bacteriol. 170, 5067-5075 (1988
15. Walter P, Johnson AE. Signal sequence recognition and protein targeting to the endoplasmic reticulum membrane. Annu. Rev. Cell Biol. 10, 87-119 (1994
16. Batenburg AM, Demel RA, Verkleij AJ, de Kruijff B. Penetration of the signal sequence of Escherichia coli PhoE protein into phospholipid model membranes leads to lipid-specific changes in signal peptide structure and alterations of lipid organization. Biochemistry 27, 5678-5685 (1988
17. De Vrije T, Batenburg AM, Jordi W, de Kruijff B. Inhibition of PhoE translocation across Escherichia coli inner-membrane vesicles by synthetic signal peptides suggests an important role of acidic phospholipids in protein translocation. Eur. J. Biochem. 180, 385-293 (1989
18. Mahagamasakera PG, Ruygrok P, Palmer SC et al. BNP forms within the heart, coronary sinus and peripheral circulation in humans: evidence for degradation prior to secretion. Clin. Chem. 60, 549-558 (2014
19. Goetze JP. B-Type natriuretic peptide: from posttranslational processing to clinical measurement. Clin. Chem. 58, 83-91 (2012
20. Weihofen A, Lemberg M, Ploegh H, Bogyo M, Martoglio B. Release of signal peptide fragments into the cytosol requires cleavage in the transmembrane region by a protease activity that is specifically blocked by a novel cysteine protease inhibitor. J. Biol. Chem. 275, 30951-30956 (2000
21. Loureiro J, Lilley B, Spooner E, Noriega V, Tortorella D, Ploegh H. Signal peptide peptidase is required for dislocation from the endoplasmic reticulum. Nature 441, 894-897 (2006
22. Braud V, Allan D, O'Callaghan C et al. HLA-E Binds to Natural Killer Cell Receptors CD94/NGK2A, B and C. Nature 391, 795-799 (1998
23. Michaelsson J, deMatos C, Achour A, Lanier L, Karre K, Soderstrom K. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NGK2A recognition. J. Exp. Med. 196, 1403-1414 (2002
24. Martoglio B, Graf R, Dobberstein B. Signal peptide fragments of preprolactin and HIV-1 p-gp160 interact with calmodulin. EMBO J. 16, 6636-6645 (1997
25. Dultz E, Hildenbeutel M, Martoglio B, Hochman J, Dobberstein B, Kapp K. The signal peptide of the mouse mammary tumor virus Rem protein is released from the endoplasmic reticulum membrane and accumulates in nucleoli. J. Biol. Chem. 283, 9966-9976 (2008
26. Lyko F, Martoglio B, Jungnickel B, Rapoport TA, Dobberstein B. Signal sequence processing in rough microsomes. J. Biol. Chem. 270, 19873-19878 (1995
27. Weihofen A, Binns K, Lemberg M, Ashman K, Martoglio B. Identification of signal peptide peptidase, a presenilin-Type aspartic protease. Science 296, 2215-2218 (2002
28. Kronenberg D, Knight R, Estorninho M et al. Circulating preproinsulin signal peptide-specific CD8 T cells restricted by the susceptibility molecule HLA-A24 are expanded at onset of Type 1 diabetes and kill β-cells. Diabetes 61, 1752-1759 (2012
29. Tousoulis D, Papageorgiou N, Androulakis E et al. Diabetes mellitus-Associated vascular impairment: novel circulating biomarkers and therapeutic approaches. J. Am. Coll. Cardiol. 62(8), 667-676 (2013
30. El Hage F, Stroobant V, Vergnon I et al. Preprocalcitonin signal peptide generates a cytotoxic T lymphocyte-defined tumor epitope processed by a proteasome-independent pathway. Proc. Natl Acad. Sci. USA 105, 10119-10124 (2008
31. Axler O, Ahnstrom J, Dahlback B. Apolipoprotein M associates to lipoproteins through its retained signal peptide. FEBS Lett. 52, 826-828 (2008
32. Christoffersen C, Ahnstrom J, Axler O, Christensen E, Dahlback B, Nielsen L. The signal peptide anchors apolipoprotein M in plasma proteins and prevents rapid clearance of apolipoprotein M from plasma. J. Biol. Chem. 283, 18765-18772 (2008
33. Sorenson R, Bisgaier C, Aviram M, Hsu C, Billecke S, La Du B. Human serum Paraoxonase/Arylesterase's retained hydrophobic N-Terminal leader sequence associates with HDLs by binding phospholipids: apolipoprotein A-I stabilizes activity. Arterioscler. Thromb. Vasc. Biol. 19, 2214-2225 (1999
34. Raper J, Fung R, Ghiso J, Nussenzweig V, Tomlinson S. Characterization of a novel trypanosome lytic factor from human serum. Infect. Immun. 67, 1910-1916 (1999
35. Liu M, Lara-Lemus R, Shan SO et al. Impaired cleavage of preproinsulin signal peptide linked to autosomal-dominant diabetes. Diabetes 61, 828-837 (2012
36. Karvonen M, Pesonen U, Koulu M et al. Association of a leucine(7)-To-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels. Nat. Med. 4, 1434-1437 (1998
37. Kallio J, Pesonen U, Kaipio K et al. Altered intracellular processing and release of neuropeptide Y due to leucine 7 to proline 7 polymorphism in the signal peptide of preproneuropeptide Y in humans. FASEB J. 15, 1242-1254 (2001
38. Siriwardena M, Kleffmann T, Ruygrok P et al. B-Type natriuretic peptide signal peptide circulates in human blood: evaluation as a potential biomarker of cardiac ischemia. Circulation 122, 255-264 (2010
39. Zhang Q, Ames JM, Smith RD, Baynes JW, Metz TO. A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease. J. Proteome Res. 8, 754-769 (2009
40. Gerbes AL, Dagnino L, Nguyen T, Nemer M. Transcription of brain natriuretic peptide and atrial natriuretic peptide genes in human tissues. J. Clin. Endocrinol. Metab. 78, 1307-1311 (1994
41. Siriwardena M, Campbell V, Richards AM, Pemberton CJ. Cardiac biomarker responses to dobutamine stress echocardiography in healthy volunteers and patients with coronary artery disease. Clin. Chem. 58, 1492-1494 (2012
42. Pemberton CJ, Siriwardena M, Kleffmann T et al. First identification of circulating prepro-A-Type natriuretic peptide (preproANP) signal peptide fragments in humans: initial assessment as cardiovascular biomarkers. Clin. Chem. 58, 757-767 (2012
43. Palmer SC, Prickett TC, Espiner EA, Yandle TG, Richards AM. Regional release and clearance of C-Type natriuretic peptides in the human circulation and relation to cardiac function. Hypertension 54, 612-618 (2009
44. Lumsden NG, Khambata RS, Hobbs AJ. C-Type natriuretic peptide (CNP): cardiovascular roles and potential as a therapeutic target. Curr. Pharm. Des. 16, 4080-4088 (2010
45. Pemberton CJ, Siriwardena M, Kleffmann T, Richards AM. C-Type natriuretic peptide (CNP) signal peptide fragments are present in the human circulation. Biochem. Biophys. Res. Commun. 449, 301-306 (2014
46. Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin. Chem. 58, 1574-1581 (2012